Literature DB >> 10556548

An alternating selection strategy for cloning phage display antibodies.

J Lu1, S R Sloan.   

Abstract

Phage display is a powerful technique that can be used to develop antibodies to target molecules. One approach for antibody phage display is to select phage from a large naive library of antibody immunoglobulin variable region fragments (Fv) expressed on the surface of phage. Phage that display antibody fragments of interest are selected by their ability to bind the target antigen immobilized on a solid support surface. A major difficulty often encountered with this approach is that phage that bind to additional antigens that are present during the phage selection steps are also selected. We have developed an alternating selection approach to minimize selection of unwanted phage. In the alternating selection approach, two selection methods are used. Each selection method contains different contaminating antigens. This approach was used to select phage that bind a phosphoryated form of the E47 transcription factor. Phage were selected based on their ability to bind a phospho-peptide in solution and alternatively a phospho-protein coated on a polyvinyl micortiter plate. This approach proved significantly better than selection with only one method. With one selection technique, 2 of 48 (4%) selected clones bound to the target antigen. With another selection technique, 15 of 48 (31%) selected clones bound to the target antigen. With alternating selection, 71 of 93 (76%) of the clones bound to the target antigen.

Mesh:

Substances:

Year:  1999        PMID: 10556548     DOI: 10.1016/s0022-1759(99)00091-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  A novel assay for monitoring internalization of nanocarrier coupled antibodies.

Authors:  Ulrik B Nielsen; Dmitri B Kirpotin; Edward M Pickering; Daryl C Drummond; James D Marks
Journal:  BMC Immunol       Date:  2006-10-02       Impact factor: 3.615

2.  Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.

Authors:  Perry Tal; Shay Eizenberger; Elad Cohen; Naomi Goldfinger; Shmuel Pietrokovski; Moshe Oren; Varda Rotter
Journal:  Oncotarget       Date:  2016-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.